Pangaea Oncology SA logo

PANG - Pangaea Oncology SA News Story

€2 0.1  2.6%

Last Trade - 14/05/21

Sector
Healthcare
Size
Micro Cap
Market Cap £32.3m
Enterprise Value £35.1m
Revenue £3.53m
Position in Universe 507th / 726

BRIEF-Pangaea Oncology Signs MoU With CRT To Renew Program Of Drug Development

Tue 2nd October, 2018 8:57am
Oct 2 (Reuters) - Pangaea Oncology SA  PANGO.MC :
    * SIGNS MOU WITH CANCER RESEARCH TECHNOLOGIES (CRT) TO RENEW PROGRAM OF DRUG DEVELOPMENT
(PAK
INHIBITORS) CURRENTLY IN FORCE
    * OBJECTIVE OF NEW AGREEMENT IS FOR PANGAEA AND CRT TO START SEARCH FOR NEW PARTNERS FOR
PROJECT

Source text: https://bit.ly/2DONm45
    
Further company coverage:  PANGO.MC 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.